HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

860.685

-4.364-0.50%

Number of Gainers:3

Number of Losers:6

Number of Flat:4

PE:- -

High:881.520

Open:863.928

Low:841.556

Close:865.049

Volume:55.59M

Turnover:395.19M

Market Cap:144.12B

Float Cap:104.67B

Loading ...

Sisram Medical Files HKEX Next-Day Return Disclosing Share Buyback

Sinopharm Group Stock Advances 1.1% in Hong Kong

Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids

Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals

Fosun Pharma Subsidiary Waives Right to Receive Transferred Shares in Biologics-Focused Equity Fund

MT Newswires Live

Hong Kong Stock Movers: CMS Surges Over 4% as Innovative Drug Ruxolitinib Phosphate Cream Wins Singapore Marketing Approval

Fosun Pharma Unit Begins Trial of FXS6837 Capsules for Gemoglobinuria in China

MT Newswires Live

Sisram Medical Announces HK$90,400 Share Buyback of 50,000 Shares on November 4

Sisram Medical Files HKEX Return Disclosing Share Repurchase

Lai Fung Announces Public Float at 14.76% as of Nov 4

Phase III Clinical Trial of FXS6837 Capsules for Paroxysmal Nocturnal Hemoglobinuria Initiated in China by Fosun Pharma

Lai Fung - Public Float at 14.76% as of Nov 4, 2026, Below Required 25%

THOMSON REUTERS

Shanghai Fosun Pharma - Subsidiary Initiates Phase Iii Trial of Fxs6837 Capsules for Pnh

THOMSON REUTERS

Fosun Pharma's Subsidiary Gains Approval for HLX109 Injection Clinical Trial in Australia

Fosun International Climbs Nearly 5% as Subsidiaries Post Strong Results; Fosun Pharma's Nine-Month Adjusted Net Profit Rises Over 8%

CMS Pharma's Innovative Drug Ruxolitinib Phosphate Cream Wins Singapore Marketing Approval

China Medical System Unit Rxilient Medical Wins Singapore Approval for Vitiligo Cream

China Medical System Holdings - Rxilient Medical Receives Hsa Approval for Nda of Ruxolitinib Phosphate Cream on Nov 3, 2026

THOMSON REUTERS

Sinopharm Group Stock Rallies 2.4% in Hong Kong

3SBIO Repurchases 6.3375 Million Shares in October to Hold as Treasury Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":860.68463,"timestamp":1793952530468,"preClose":865.0486,"halted":0,"volume":55592590,"delay":0,"changeRate":-0.005045,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-4.363953,"latestTime":"11-06 16:00:00","open":863.9281,"high":881.51965,"low":841.5564,"amount":395187575.5,"amplitude":0.046198,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1793928600000,1793937600000],[1793941200000,1793952000000]],"pbRate":1.11105,"peRate":10.148077,"turnoverRate":0.002705,"increases":3,"decrements":7,"flats":3,"marketCap":144123646896,"floatMarketCap":104669312304},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":881.51965,"amplitude":0.046198,"preClose":865.0486,"low":841.5564,"pbRate":"1.11105","latestPrice":860.68463,"volume":55592590,"delay":0,"open":863.9281,"prevYearClose":1094.978,"prevWeekClose":798.351,"prevMonthClose":798.351,"prevQuarterClose":907.15,"fiveDayClose":798.351,"twentyDayClose":856.485,"sixtyDayClose":956.832,"secType":"PLATE","market":"HK","turnoverRate":0.002705,"peRate":10.148077,"marketCap":144123646896,"floatMarketCap":104669312304,"timestamp":1793952530468,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":3,"down":6,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2681852365","title":"Sisram Medical Files HKEX Next-Day Return Disclosing Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2681852365","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681852365?lang=en_us&edition=fundamental","pubTime":"2026-11-06 18:11","pubTimestamp":1793959919,"startTime":"0","endTime":"0","summary":"Sisram Medical Files HKEX Next-Day Return Disclosing Share BuybackSisram Medical repurchased 14,800 shares for HKD 26,558 on November 6, 2026.Repurchase prices ranged from HKD 1.775 to HKD 1.8 per sha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261106:nNDL4BcsNM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","BK1585","01696","00656","BK1100","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681855108","title":"Sinopharm Group Stock Advances 1.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2681855108","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681855108?lang=en_us&edition=fundamental","pubTime":"2026-11-06 16:33","pubTimestamp":1793953980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 1.1% to 17.16 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 24481.86.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 23% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 0.1%.Trading volume totaled 6.1 million shares, compared to the 50-day average of 5.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK4175","SHTDY","BK0028","BK0183","01099","BK0188","BK0175","600196","BK1197","02196","BK0012","BK1191","BK0060","LU1115378108.SGD","LU0640798160.USD","BK0196","BK0096","BK0187","BK0239","BK1500","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681076733","title":"Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids","url":"https://stock-news.laohu8.com/highlight/detail?id=2681076733","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681076733?lang=en_us&edition=fundamental","pubTime":"2026-11-05 21:00","pubTimestamp":1793883600,"startTime":"0","endTime":"0","summary":"New direct practice expense supply code supports more consistent valuation of CPT 0563TMENLO PARK, Calif., Nov.  05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/05/3396356/0/en/sight-sciences-announces-cms-establishment-of-a-practice-expense-supply-code-for-tearcare-smartlids.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2346227817.USD","LU1894683264.USD","SG9999004220.SGD","PFS","BK4211","LU0949170772.SGD","LU2500361329.USD","SG9999015952.SGD","IE00BVYPNQ40.USD","BK4208","SG9999015978.USD","00867","BK1191","BK4539","CMS","LU1894683348.USD","BK1593","BK4082","IE00BGHQDM52.EUR","LU0545039389.USD","IE00BYV24P56.USD","SGHT","BK4195","BK4588","BK4585","LU1003077747.HKD","LU2637428348.USD","LU0738911758.USD","IE00BMCWC346.EUR","SG9999015986.USD","LU0661504455.SGD","SG9999015945.SGD","SG9999004311.SGD","IE00BVYPNP33.GBP","LU2488822045.USD","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681783140","title":"Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2681783140","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681783140?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:15","pubTimestamp":1793880900,"startTime":"0","endTime":"0","summary":"Final rule maintains separate payment for advanced diagnostic imaging agents and confirms PYLARIFY TruVu Transitional Pass-Through status through September 30, 2029; permanent HCPCS code A9613 now in ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/05/3396291/0/en/lantheus-welcomes-cms-cy27-final-rule-advancing-access-to-diagnostic-radiopharmaceuticals.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","IE00BVYPNP33.GBP","ADT.AU","BK1593","REZ","SG9999015952.SGD","CMS","BK1191","BK4217","INDS","SG9999004311.SGD","BK4533","LU1894683264.USD","PSA","BK4192","SG9999015945.SGD","BK4198","SG9999004220.SGD","BK4588","LU1003077747.HKD","BK4585","LU0545039389.USD","LU2488822045.USD","BK7047","IE00BVYPNQ40.USD","PET.AU","LU0738911758.USD","BK7142","BK4165","LNTH","ADT","IE00BGHQDM52.EUR","BK4208","LU0949170772.SGD","BK4084","IE00BMCWC346.EUR","PSA.AU","SG9999015986.USD","LU2346227817.USD","IE00BYV24P56.USD","REAI","SG9999015978.USD","LU1894683348.USD","HAUS","LU2637428348.USD","BK7095","LU2500361329.USD","00867","LU0661504455.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681801653","title":"Fosun Pharma Subsidiary Waives Right to Receive Transferred Shares in Biologics-Focused Equity Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2681801653","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681801653?lang=en_us&edition=fundamental","pubTime":"2026-11-05 11:29","pubTimestamp":1793849353,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical's  subsidiary, Suzhou Junming, agreed to the addition of a new investor in its biologics-focused private equity fund, Hangzhou Fund, and waived its right to receive shares transferred from another investor, according to a Shanghai bourse filing Thursday.Porton Pharma Solutions acquired the 3.75% stake in the fund, which is worth 30 million yuan, from Ningbo Xinhui.After the transaction, Ningbo Xinhui's share in the fund was reduced to 3.13% from 6.88%.The pharmaceutical company's Shanghai and Hong Kong shares both rose 1% during the morning trade.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0028","BK1515","BK4585","BK4588","BK0060","600196","BK1191","BK0188","BK0239","BK0187","BK0096","BK0012","REZ","02196","BK4215","EQR","BK0175","BK0196","BK0183","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103656415","title":"Hong Kong Stock Movers: CMS Surges Over 4% as Innovative Drug Ruxolitinib Phosphate Cream Wins Singapore Marketing Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1103656415","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103656415?lang=en_us&edition=fundamental","pubTime":"2026-11-05 11:08","pubTimestamp":1793848097,"startTime":"0","endTime":"0","summary":"Shares of CMS (00867) rose more than 4%, reaching 4.24% higher at HK$10.57 as of press time, with turnover of HK$10.9292 million.On the news front, on November 4, CMS announced that its subsidiary...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","MEDX","SG9999015978.USD","BK1593","BK4585","LU2488822045.USD","SG9999004220.SGD","SG9999004311.SGD","VXUS","KCAI","IPOS","LNGR","BK1191","BK1161","IE00BGHQDM52.EUR","06978","IE00BYV24P56.USD","IE00BVYPNP33.GBP","IBBQ","SG9999015945.SGD","BK4588","IE00BVYPNQ40.USD","SG9999015986.USD","00867","IE00BMCWC346.EUR","STmain","SG9999015952.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680032106","title":"Fosun Pharma Unit Begins Trial of FXS6837 Capsules for Gemoglobinuria in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2680032106","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680032106?lang=en_us&edition=fundamental","pubTime":"2026-11-04 18:50","pubTimestamp":1793789439,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical   unit Shanghai Fosun Pharmaceutical Industrial Development began the phase III clinical trial of FXS6837 capsules.The drug is being tested for the treatment of paroxysmal nocturnal hemoglobinuria in the Chinese mainland, a Wednesday bourse filing showed.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0187","BK0188","BK0096","BK0028","BK0239","02196","BK0060","BK0183","BK1515","BK1593","BK0175","BK0196","BK1191","600196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172878855","title":"Sisram Medical Announces HK$90,400 Share Buyback of 50,000 Shares on November 4","url":"https://stock-news.laohu8.com/highlight/detail?id=1172878855","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172878855?lang=en_us&edition=fundamental","pubTime":"2026-11-04 18:46","pubTimestamp":1793789181,"startTime":"0","endTime":"0","summary":"Sisram Medical Ltd (01696) has announced that on November 4, 2026, the company repurchased 50,000 shares at a total cost of approximately HK$90,400.The buyback was executed at a price ranging between HK$1.77 and HK$1.82 per share.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01696","BK1100","BK1593","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680032658","title":"Sisram Medical Files HKEX Return Disclosing Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2680032658","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680032658?lang=en_us&edition=fundamental","pubTime":"2026-11-04 18:45","pubTimestamp":1793789116,"startTime":"0","endTime":"0","summary":"Sisram Medical Files HKEX Return Disclosing Share RepurchaseSisram Medical repurchased 50,000 ordinary shares for HKD 90,396 on November 4, 2026.Repurchase prices ranged from HKD 1.77 to HKD 1.82 per ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL4HjVwp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","BK1585","BK1100","BK1593","01696","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680034903","title":"Lai Fung Announces Public Float at 14.76% as of Nov 4","url":"https://stock-news.laohu8.com/highlight/detail?id=2680034903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680034903?lang=en_us&edition=fundamental","pubTime":"2026-11-04 18:24","pubTimestamp":1793787848,"startTime":"0","endTime":"0","summary":"BRIEF-Lai Fung Announces Public Float At 14.76% As Of Nov 4Nov 4 (Reuters)-Lai Fung Holdings Ltd1125.HK:PUBLIC FLOAT AT 14.76% AS OF NOV 4, 2026, BELOW REQUIRED 25%Further company coverage:1125.HK","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nFWN46L0VX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1240","01125"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179429142","title":"Phase III Clinical Trial of FXS6837 Capsules for Paroxysmal Nocturnal Hemoglobinuria Initiated in China by Fosun Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1179429142","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179429142?lang=en_us&edition=fundamental","pubTime":"2026-11-04 17:52","pubTimestamp":1793785936,"startTime":"0","endTime":"0","summary":"Fosun Pharma (02196) has issued an announcement that its controlling subsidiary, Shanghai Fosun Pharmaceutical Industry Development Co., Ltd., has launched a Phase III clinical trial in China for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196","BK0183","BK0239","BK0196","IBBQ","BK0188","600196","BK0028","BK0096","BK1515","BMED","BK0060","MDTX","BK0012","BK0187","BK1593","BK1191","BK0175","IBBJ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680372031","title":"Lai Fung - Public Float at 14.76% as of Nov 4, 2026, Below Required 25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680372031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680372031?lang=en_us&edition=fundamental","pubTime":"2026-11-04 17:52","pubTimestamp":1793785934,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nFWN46L0VX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1240","BK1593","01125"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680039067","title":"Shanghai Fosun Pharma - Subsidiary Initiates Phase Iii Trial of Fxs6837 Capsules for Pnh","url":"https://stock-news.laohu8.com/highlight/detail?id=2680039067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680039067?lang=en_us&edition=fundamental","pubTime":"2026-11-04 17:48","pubTimestamp":1793785733,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nFWN46L0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0096","BK0012","600196","BK0060","BK0183","BK0196","BK1191","BK0239","02196","BK0187","BK0175","BK1515","BK0028","BK1593","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133724447","title":"Fosun Pharma's Subsidiary Gains Approval for HLX109 Injection Clinical Trial in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=1133724447","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133724447?lang=en_us&edition=fundamental","pubTime":"2026-11-04 17:12","pubTimestamp":1793783531,"startTime":"0","endTime":"0","summary":"Fosun Pharma (600196.SH) has announced that its controlling subsidiary Shanghai Henlius Biotech, Inc. and its controlled subsidiaries (collectively \"Henlius\") have received approval from the relevant...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK0239","BK1593","BMED","02196","BK0060","BK0028","BK0188","BK1191","PSYK","BK0012","MDTX","BK0175","BK1515","IBBJ","BK0096","IBBQ","BK0183","600196","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124334568","title":"Fosun International Climbs Nearly 5% as Subsidiaries Post Strong Results; Fosun Pharma's Nine-Month Adjusted Net Profit Rises Over 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124334568","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124334568?lang=en_us&edition=fundamental","pubTime":"2026-11-04 16:24","pubTimestamp":1793780656,"startTime":"0","endTime":"0","summary":"Fosun International (00656) closed nearly 5% higher. The stock ended the day up 4.74% at HK$4.64, with turnover of HK$30.67 million. On the news front, several listed companies under Fosun...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600196","BK0175","BK0196","BK0096","BK0239","BK1593","BK1515","BK0183","BK0188","BK0060","BK4588","00656","BK1191","BK0187","BK4585","BK1230","VXUS","BK0012","KCAI","BK0028","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128615092","title":"CMS Pharma's Innovative Drug Ruxolitinib Phosphate Cream Wins Singapore Marketing Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1128615092","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128615092?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:40","pubTimestamp":1793745622,"startTime":"0","endTime":"0","summary":"CMS (00867) has announced that its subsidiary Rxilient Medical received approval from the Health Sciences Authority of Singapore (HSA) on November 3, 2026, for the New Drug Application (NDA) of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQDM52.EUR","LNGR","BK1191","IBBQ","BK1574","IE00BVYPNQ40.USD","SG9999015978.USD","STmain","00867","IE00BYV24P56.USD","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","SG9999015952.SGD","BK1593","159992","SG9999015986.USD","SG9999004311.SGD","SG9999015945.SGD","IPOS","BK1161","06978","SG9999004220.SGD","LU2488822045.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680870569","title":"China Medical System Unit Rxilient Medical Wins Singapore Approval for Vitiligo Cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2680870569","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680870569?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:34","pubTimestamp":1793745273,"startTime":"0","endTime":"0","summary":"China Medical System Unit Rxilient Medical Wins Singapore Approval for Vitiligo CreamChina Medical System subsidiary Rxilient Medical secured Singapore approval for ruxolitinib phosphate cream, brande","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL7sl3fT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","00867","IE00BGHQDM52.EUR","SG9999015978.USD","SG9999004311.SGD","SG9999015945.SGD","IE00BVYPNQ40.USD","SG9999004220.SGD","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","IE00BYV24P56.USD","LU2488822045.USD","SG9999015952.SGD","BK1191","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680703111","title":"China Medical System Holdings - Rxilient Medical Receives Hsa Approval for Nda of Ruxolitinib Phosphate Cream on Nov 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2680703111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680703111?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:10","pubTimestamp":1793743827,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nFWN46K29O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00867","BK1191","SG9999004311.SGD","BK1593","SG9999004220.SGD","SG9999015945.SGD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","SG9999015952.SGD","IE00BVYPNQ40.USD","IE00BYV24P56.USD","SG9999015986.USD","IE00BMCWC346.EUR","LU2488822045.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680574304","title":"Sinopharm Group Stock Rallies 2.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2680574304","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680574304?lang=en_us&edition=fundamental","pubTime":"2026-11-03 16:33","pubTimestamp":1793694780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. rallied 2.4% to 16.73 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 23525.97.This was the stock's third consecutive day of gains.Sinopharm Group Co. Ltd. closed 25% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 1.6%.Trading volume totaled 8.1 million shares, compared to the 50-day average of 5.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK4175","SHTDY","BK1515","BK1197","BK0096","BK1191","600196","BK0188","LU0640798160.USD","BK1593","BK1500","BK0187","BK0239","BK0196","LU1115378108.SGD","01099","BK0028","02196","BK0060","BK0183","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112173563","title":"3SBIO Repurchases 6.3375 Million Shares in October to Hold as Treasury Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1112173563","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112173563?lang=en_us&edition=fundamental","pubTime":"2026-11-02 20:21","pubTimestamp":1793622064,"startTime":"0","endTime":"0","summary":"On November 2, 3SBIO (01530.HK) announced that it submitted its monthly return of securities movements to the Hong Kong Stock Exchange for the month ended October 31, 2026.Between October 8 and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1583","BK1161","01530","BK1593"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}